Corticosteroids for Non-severe COVID-19: Primum Non Nocere

Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN, Agarwal R. Corticosteroids for Non-severe COVID-19: Primum Non Nocere. Indian J Crit Care Med 2022;26(3):403–404.

Detalles Bibliográficos
Autores principales: Muthu, Valliappan, Sehgal, Inderpaul S, Dhooria, Sahajal, Prasad, Kuruswamy Thurai, Aggarwal, Ashutosh N, Agarwal, Ritesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015934/
https://www.ncbi.nlm.nih.gov/pubmed/35519931
http://dx.doi.org/10.5005/jp-journals-10071-24138
_version_ 1784688418808135680
author Muthu, Valliappan
Sehgal, Inderpaul S
Dhooria, Sahajal
Prasad, Kuruswamy Thurai
Aggarwal, Ashutosh N
Agarwal, Ritesh
author_facet Muthu, Valliappan
Sehgal, Inderpaul S
Dhooria, Sahajal
Prasad, Kuruswamy Thurai
Aggarwal, Ashutosh N
Agarwal, Ritesh
author_sort Muthu, Valliappan
collection PubMed
description Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN, Agarwal R. Corticosteroids for Non-severe COVID-19: Primum Non Nocere. Indian J Crit Care Med 2022;26(3):403–404.
format Online
Article
Text
id pubmed-9015934
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-90159342022-05-04 Corticosteroids for Non-severe COVID-19: Primum Non Nocere Muthu, Valliappan Sehgal, Inderpaul S Dhooria, Sahajal Prasad, Kuruswamy Thurai Aggarwal, Ashutosh N Agarwal, Ritesh Indian J Crit Care Med Letter to the Editor Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN, Agarwal R. Corticosteroids for Non-severe COVID-19: Primum Non Nocere. Indian J Crit Care Med 2022;26(3):403–404. Jaypee Brothers Medical Publishers 2022-03 /pmc/articles/PMC9015934/ /pubmed/35519931 http://dx.doi.org/10.5005/jp-journals-10071-24138 Text en Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Muthu, Valliappan
Sehgal, Inderpaul S
Dhooria, Sahajal
Prasad, Kuruswamy Thurai
Aggarwal, Ashutosh N
Agarwal, Ritesh
Corticosteroids for Non-severe COVID-19: Primum Non Nocere
title Corticosteroids for Non-severe COVID-19: Primum Non Nocere
title_full Corticosteroids for Non-severe COVID-19: Primum Non Nocere
title_fullStr Corticosteroids for Non-severe COVID-19: Primum Non Nocere
title_full_unstemmed Corticosteroids for Non-severe COVID-19: Primum Non Nocere
title_short Corticosteroids for Non-severe COVID-19: Primum Non Nocere
title_sort corticosteroids for non-severe covid-19: primum non nocere
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015934/
https://www.ncbi.nlm.nih.gov/pubmed/35519931
http://dx.doi.org/10.5005/jp-journals-10071-24138
work_keys_str_mv AT muthuvalliappan corticosteroidsfornonseverecovid19primumnonnocere
AT sehgalinderpauls corticosteroidsfornonseverecovid19primumnonnocere
AT dhooriasahajal corticosteroidsfornonseverecovid19primumnonnocere
AT prasadkuruswamythurai corticosteroidsfornonseverecovid19primumnonnocere
AT aggarwalashutoshn corticosteroidsfornonseverecovid19primumnonnocere
AT agarwalritesh corticosteroidsfornonseverecovid19primumnonnocere

Ejemplares similares